Contribution of skeletal muscle to cancer immunotherapy: A focus on muscle function, inflammation, and microbiota

Yuanle Deng1, Ling Zhao1, Xuemei Huang1

  • 1Department of Clinical Nutrition, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Sichuan, China.

Insights

Sarcopenia, or low muscle mass, negatively impacts cancer immunotherapy effectiveness and immune-related side effects in most patients. Nutritional interventions may improve immunotherapy outcomes for cancer patients with sarcopenia.

Area of Science:

  • Oncology
  • Immunology
  • Geriatrics

Background:

  • Sarcopenia, a loss of muscle mass and function, is common in cancer patients.
  • It signifies poor nutritional status and potential cancer cachexia.
  • The impact of sarcopenia on cancer immunotherapy is a growing area of research.

Purpose of the Study:

  • To review the influence of sarcopenia/cachexia on cancer immunotherapy response.
  • To analyze effects on immune-related adverse events.
  • To explore potential mechanisms and confounding factors.

Main Methods:

  • Literature review of recent studies.
  • Analysis of data on sarcopenia/cachexia and immunotherapy outcomes.
  • Discussion of inconsistencies and potential explanations.

Main Results:

  • Low muscle mass generally has detrimental effects on cancer immunotherapy efficacy.
  • Inconsistencies in findings were observed, attributed to varied methodologies.
  • Chronic inflammation, immune cells, and microbiota are implicated mechanistically.

Conclusions:

  • Sarcopenia is a significant prognostic factor in cancer immunotherapy.
  • Nutritional interventions show promise for enhancing immunotherapy efficacy.
  • Further research is needed to clarify the complex relationship and optimize interventions.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
639
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.0K
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K